Opinion|Videos|November 11, 2025

Tapinarof Efficacy and Safety in Pediatric AD Care

Panelists discuss how clinical results confirm the effectiveness, safety, and caregiver convenience of new nonsteroidal therapies for pediatric AD.

Panelists discuss how recent studies have shown that certain nonsteroidal treatments can be effective and safe for children across all disease severities. They highlight strong results in both short-term symptom relief and long-term skin stability, with children experiencing reduced itch and visible improvement.

Caregivers report satisfaction with simple, once-daily applications that fit smoothly into daily routines. Minimal systemic absorption and consistent safety findings provide reassurance for families managing chronic conditions in young children.

These results align with clinicians’ real-world experiences, reinforcing the importance of well-tolerated, easy-to-use options that enhance quality of life for children and caregivers alike.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.